Levels of interleukins 2, 6, 8, and 10 in patients with irritable bowel syndrome

Irritable bowel syndrome (IBS) was previously considered as a psychosomatic disorder. But recent studies indicate that inflammation plays a significant role. The present study was undertaken to evaluate role of pro-inflammatory (IL 2, IL 6 and IL 8) and anti-inflammatory (IL 10) cytokines in clinica...

Full description

Bibliographic Details
Main Authors: Shaileshkumar R Patel, Anshul Singh, Vatsala Misra, Sri Prakash Misra, Manisha Dwivedi, Pawan Trivedi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2017;volume=60;issue=3;spage=385;epage=389;aulast=Patel
_version_ 1818063543111516160
author Shaileshkumar R Patel
Anshul Singh
Vatsala Misra
Sri Prakash Misra
Manisha Dwivedi
Pawan Trivedi
author_facet Shaileshkumar R Patel
Anshul Singh
Vatsala Misra
Sri Prakash Misra
Manisha Dwivedi
Pawan Trivedi
author_sort Shaileshkumar R Patel
collection DOAJ
description Irritable bowel syndrome (IBS) was previously considered as a psychosomatic disorder. But recent studies indicate that inflammation plays a significant role. The present study was undertaken to evaluate role of pro-inflammatory (IL 2, IL 6 and IL 8) and anti-inflammatory (IL 10) cytokines in clinically diagnosed patients of IBS. 51 patients and 29 controls were included in this study. On the basis of history of gastrointestinal infection, patients were divided into Post Infectious (PIIBS) and Non Post Infectious (NPIIBS) groups. All subsequently underwent colonoscopy and a rectosigmoid biopsy as well as measurement of levels of IL 2, 6, 8 and 10. The levels of IL 2 and IL 8 were significantly raised in IBS patients compared to controls with the mean level of IL 2,6 and 8 higher in PIIBS group than NPIIBS group but statistically significant for IL 8 only. The mean level IL-10 was reduced in patients compared to controls but statistically insignificant. Present study shows that Interleukin levels are altered in patients suffering from IBS and may have a key role in its pathogenesis.
first_indexed 2024-12-10T14:21:46Z
format Article
id doaj.art-eed932335d624a4da0c5d20bee5e0aeb
institution Directory Open Access Journal
issn 0377-4929
language English
last_indexed 2024-12-10T14:21:46Z
publishDate 2017-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Pathology and Microbiology
spelling doaj.art-eed932335d624a4da0c5d20bee5e0aeb2022-12-22T01:45:10ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49292017-01-0160338538910.4103/IJPM.IJPM_544_16Levels of interleukins 2, 6, 8, and 10 in patients with irritable bowel syndromeShaileshkumar R PatelAnshul SinghVatsala MisraSri Prakash MisraManisha DwivediPawan TrivediIrritable bowel syndrome (IBS) was previously considered as a psychosomatic disorder. But recent studies indicate that inflammation plays a significant role. The present study was undertaken to evaluate role of pro-inflammatory (IL 2, IL 6 and IL 8) and anti-inflammatory (IL 10) cytokines in clinically diagnosed patients of IBS. 51 patients and 29 controls were included in this study. On the basis of history of gastrointestinal infection, patients were divided into Post Infectious (PIIBS) and Non Post Infectious (NPIIBS) groups. All subsequently underwent colonoscopy and a rectosigmoid biopsy as well as measurement of levels of IL 2, 6, 8 and 10. The levels of IL 2 and IL 8 were significantly raised in IBS patients compared to controls with the mean level of IL 2,6 and 8 higher in PIIBS group than NPIIBS group but statistically significant for IL 8 only. The mean level IL-10 was reduced in patients compared to controls but statistically insignificant. Present study shows that Interleukin levels are altered in patients suffering from IBS and may have a key role in its pathogenesis.http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2017;volume=60;issue=3;spage=385;epage=389;aulast=PatelCytokinesinflammationinterleukinsirritable bowel syndromepathogenesis
spellingShingle Shaileshkumar R Patel
Anshul Singh
Vatsala Misra
Sri Prakash Misra
Manisha Dwivedi
Pawan Trivedi
Levels of interleukins 2, 6, 8, and 10 in patients with irritable bowel syndrome
Indian Journal of Pathology and Microbiology
Cytokines
inflammation
interleukins
irritable bowel syndrome
pathogenesis
title Levels of interleukins 2, 6, 8, and 10 in patients with irritable bowel syndrome
title_full Levels of interleukins 2, 6, 8, and 10 in patients with irritable bowel syndrome
title_fullStr Levels of interleukins 2, 6, 8, and 10 in patients with irritable bowel syndrome
title_full_unstemmed Levels of interleukins 2, 6, 8, and 10 in patients with irritable bowel syndrome
title_short Levels of interleukins 2, 6, 8, and 10 in patients with irritable bowel syndrome
title_sort levels of interleukins 2 6 8 and 10 in patients with irritable bowel syndrome
topic Cytokines
inflammation
interleukins
irritable bowel syndrome
pathogenesis
url http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2017;volume=60;issue=3;spage=385;epage=389;aulast=Patel
work_keys_str_mv AT shaileshkumarrpatel levelsofinterleukins268and10inpatientswithirritablebowelsyndrome
AT anshulsingh levelsofinterleukins268and10inpatientswithirritablebowelsyndrome
AT vatsalamisra levelsofinterleukins268and10inpatientswithirritablebowelsyndrome
AT sriprakashmisra levelsofinterleukins268and10inpatientswithirritablebowelsyndrome
AT manishadwivedi levelsofinterleukins268and10inpatientswithirritablebowelsyndrome
AT pawantrivedi levelsofinterleukins268and10inpatientswithirritablebowelsyndrome